company

After a 26% jump, walk away from this stock: Traders – CNBC.com

How to trade a skyrocketing stock
How do you trade jumping shares of Williams now? Todd Gordon discusses with Brian Sullivan.
Shares of Williams Cos. soared 26 percent on news that the energy company rejected a $64 per share takeover offer from Energy Transfer Equity.In a statement, Williams said the proposal “significantly undervalues Williams.”Williams further announced that it has retained Barclays and […]

GoPro (NASDAQ:GPRO), (AMBA) – People Trading Out Of GoPro …

Related GPROWorst Performing Industries For June 22, 2015Monday’s Mid-Day Movers: Williams Companies, GoPro, Ambarella And MoreNasdaq Jumps To New Record High; IPOs Fitbit, Fogo On Fire Again(Investor’s Business Daily)Related Mid-Afternoon Market Update: Williams Surges Following Bid from ETE; Ambarella Shares SlideShort-Sellers Are Betting Against These StocksNasdaq Jumps To New Record High; IPOs Fitbit, Fogo On Fire Again(Investor’s Business Daily)Shares of […]

These Promising Cancer Therapies Are a Biotech Stocks "Triple Play"

These Promising Cancer Therapies Are a Biotech Stocks “Triple Play”Companies / BioTechJun 19, 2015 – 03:04 PM GMTBy: Money_MorningErnie Tremblay writes: On Jan. 7, 2015, CytRX Corp. (NASDAQ: CYTR) announced positive results from a study of its experimental brain cancer drug, aldoxorubicin, and the company’s stock immediately jumped 15.8%. Then, over the next four months, it nearly doubled.Over the months […]

Fitbit Debuts On The Stock Market, Now Valued At Over $6 Billion

As it stands, Fitbit is the current leader in the wearables market, although it appears that Xiaomi could be catching up, but in the meantime the company has recently made their debut on the stock market in the US where they held an IPO where their stocks were offered at $20 per share, giving them a valuation of about $4.1 […]

Fitbit makes stock market debut, share price jumps by more than 50%

–A+Fitbit makes stock market debut, share price jumps by more than 50%By AppleInsider StaffThursday, June 18, 2015, 11:16 am PT (02:16 pm ET)Wearable fitness tracker firm Fitbit, which competes with the Apple Watch with its own hardware, began trading on the New York Stock Exchange Wednesday, and investors promptly drove the company’s share price up by more than 50 percent […]

Fitbit begins trading at $30.40 per share, up 52% from IPO price …

Got email marketing? We’ve got best practices from LivingSocial and estate sale guru Everything But The House in our next Insight webinar.
Update at market close: Fitbit closes flat at $29.68 a share.NEW YORK — This morning Fitbit (FIT) began trading on the New York Stock Exchange at $30.40 per share. Yesterday the company set its opening price at $20 a share.Throughout the […]

Capitalize on Comeback Stories in Micro-Cap Biotech: Joe Pantginis of ROTH Capital Partners

The list of problems with investing in micro-cap biotech stocks begins with extreme volatility and lack of liquidity and ends with the inability to get validation from sophisticated investors who are unable to own such small companies.
Nevertheless, sift through the pile and investors can find gems. Joseph Pantginis of ROTH Capital Partners recognizes the characteristics that make some of these […]

Keep an Eye on These 7 Stocks for June 17, 2015 – Benzinga

Related FDXEarnings Scheduled For June 17, 2015Jill Malandrino Details What To Know Ahead Of FedEx EarningsStocks End Near Highs; Perrigo Rebounds On Mylan Deal(Investor’s Business Daily)Related ORCLEarnings Scheduled For June 17, 2015Key Earnings On Deck: FedEx, Adobe & MoreThe Vetr community has downgraded $ORCL to 3-Stars(Vetr)Some of the stocks that may grab investor focus today are:Wall Street expects FedEx Corporation […]

Biotech Stock News (RXII)(REGN)(SNY)(ESPR)(ISIS)(BIIB) | CNA …

Rxi Pharmaceuticals (NASDAQ:RXII)On June 9, 2015 shares of Rxi Pharmaceuticals went up 6% after the company reported that two new key patents were given to the company for use with their self-delivering sd-rxRNA technology platform. The new patents establish a few new details that enhance upon the company’s prospects:First the new patent is for a chemical modification that allows for […]

Maturing Pipeline Boosts Biogen Earnings

The growth is just getting started at Biogen Idec (NASDAQ: BIIB ) . OK, so it’s been ongoing for quite some time, but it certainly isn’t about to end anytime soon. The company recently launched Tecfidera for multiple sclerosis in the United States, completed three regulatory filings, is expecting three market launches in 2014, and has major trials releasing data […]